Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-03

Clinical Trial Update: A Clinical Trial Investigating Iloprost as Medication to Improve Bone Healing in Patients With Proximal Humeral Fracture [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating iloprost for improving bone healing in proximal humeral fracture (Phase 1/Phase 2). Status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iloprost (iloprost)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Proximal Humeral Fracture | Phase 1, Phase 2 | Status: UNKNOWN